Unitedhealth Group Incorporated Stock Alpha and Beta Analysis

UNH Stock  USD 492.45  0.52  0.11%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as UnitedHealth Group Incorporated. It also helps investors analyze the systematic and unsystematic risks associated with investing in UnitedHealth Group over a specified time horizon. Remember, high UnitedHealth Group's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to UnitedHealth Group's market risk premium analysis include:
Beta
0.38
Alpha
(0.08)
Risk
1.56
Sharpe Ratio
(0.01)
Expected Return
(0.01)
Please note that although UnitedHealth Group alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., NYSE Composite index.) So in this particular case, UnitedHealth Group did 0.08  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of UnitedHealth Group Incorporated stock's relative risk over its benchmark. UnitedHealth Group has a beta of 0.38  . As returns on the market increase, UnitedHealth Group's returns are expected to increase less than the market. However, during the bear market, the loss of holding UnitedHealth Group is expected to be smaller as well. As of now, UnitedHealth Group's Book Value Per Share is increasing as compared to previous years. The UnitedHealth Group's current Enterprise Value is estimated to increase to about 501.8 B, while Tangible Book Value Per Share is forecasted to increase to (20.48).

UnitedHealth Group Quarterly Cash And Equivalents

44.1 Billion

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out UnitedHealth Group Backtesting, UnitedHealth Group Valuation, UnitedHealth Group Correlation, UnitedHealth Group Hype Analysis, UnitedHealth Group Volatility, UnitedHealth Group History and analyze UnitedHealth Group Performance.

UnitedHealth Group Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. UnitedHealth Group market risk premium is the additional return an investor will receive from holding UnitedHealth Group long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in UnitedHealth Group. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate UnitedHealth Group's performance over market.
α-0.08   β0.38

UnitedHealth Group expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of UnitedHealth Group's Buy-and-hold return. Our buy-and-hold chart shows how UnitedHealth Group performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

UnitedHealth Group Market Price Analysis

Market price analysis indicators help investors to evaluate how UnitedHealth Group stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading UnitedHealth Group shares will generate the highest return on investment. By understating and applying UnitedHealth Group stock market price indicators, traders can identify UnitedHealth Group position entry and exit signals to maximize returns.

UnitedHealth Group Return and Market Media

The median price of UnitedHealth Group for the period between Mon, Feb 5, 2024 and Sun, May 5, 2024 is 491.66 with a coefficient of variation of 4.38. The daily time series for the period is distributed with a sample standard deviation of 21.48, arithmetic mean of 490.31, and mean deviation of 16.02. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
 
UnitedHealth Group dividend paid on 19th of March 2024
03/19/2024
1
UnitedHealth Group Stock Moves -0.57 percent What You Should Know
04/12/2024
2
UnitedHealth Reports Processing Issues at Change Healthcare
04/18/2024
3
UnitedHealth Groups CEO realized 25 million in 2023
04/24/2024
4
UnitedHealth hackers took advantage of Citrix vulnerabilty to break in, CEO says
04/29/2024
5
Change Healthcare hacked through stolen password for account with no MFA
04/30/2024
6
UnitedHealth CEO admits it paid 22 million ransom to BlackCat
05/01/2024
7
Earnings call Novo Nordisk reports a 24 percent increase in sales
05/02/2024
8
Acquisition by Dirk McMahon of tradable shares of UnitedHealth Group subject to Rule 16b-3
05/03/2024

About UnitedHealth Group Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including UnitedHealth or other stocks. Alpha measures the amount that position in UnitedHealth Group has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2024 (projected)
Dividend Yield0.01120.01210.0145
Price To Sales Ratio1.661.541.17

UnitedHealth Group Upcoming Company Events

As portrayed in its financial statements, the presentation of UnitedHealth Group's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, UnitedHealth Group's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of UnitedHealth Group's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of UnitedHealth Group. Please utilize our Beneish M Score to check the likelihood of UnitedHealth Group's management manipulating its earnings.
12th of April 2024
Upcoming Quarterly Report
View
12th of July 2024
Next Financial Report
View
31st of March 2024
Next Fiscal Quarter End
View
10th of January 2025
Next Fiscal Year End
View
31st of December 2023
Last Quarter Report
View
31st of December 2023
Last Financial Announcement
View

Build Portfolio with UnitedHealth Group

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether UnitedHealth Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of UnitedHealth Group's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unitedhealth Group Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Unitedhealth Group Incorporated Stock:

Complementary Tools for UnitedHealth Stock analysis

When running UnitedHealth Group's price analysis, check to measure UnitedHealth Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UnitedHealth Group is operating at the current time. Most of UnitedHealth Group's value examination focuses on studying past and present price action to predict the probability of UnitedHealth Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UnitedHealth Group's price. Additionally, you may evaluate how the addition of UnitedHealth Group to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
CEOs Directory
Screen CEOs from public companies around the world
Bonds Directory
Find actively traded corporate debentures issued by US companies
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
UnitedHealth Group technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of UnitedHealth Group technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of UnitedHealth Group trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...